GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Viva Biotech Holdings (FRA:VB0) » Definitions » Additional Paid-In Capital

Viva Biotech Holdings (FRA:VB0) Additional Paid-In Capital : €508.2 Mil(As of Dec. 2024)


View and export this data going back to 2019. Start your Free Trial

What is Viva Biotech Holdings Additional Paid-In Capital?


Viva Biotech Holdings's quarterly additional paid-in capital declined from Dec. 2023 (€497.6 Mil) to Jun. 2024 (€0.0 Mil) but then increased from Jun. 2024 (€0.0 Mil) to Dec. 2024 (€508.2 Mil).

Viva Biotech Holdings's annual additional paid-in capital increased from Dec. 2022 (€492.5 Mil) to Dec. 2023 (€497.6 Mil) and increased from Dec. 2023 (€497.6 Mil) to Dec. 2024 (€508.2 Mil).


Viva Biotech Holdings Additional Paid-In Capital Historical Data

The historical data trend for Viva Biotech Holdings's Additional Paid-In Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Viva Biotech Holdings Additional Paid-In Capital Chart

Viva Biotech Holdings Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Additional Paid-In Capital
Get a 7-Day Free Trial Premium Member Only - 505.35 492.46 497.55 508.17

Viva Biotech Holdings Semi-Annual Data
Dec16 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Additional Paid-In Capital Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 492.46 468.75 497.55 - 508.17

Viva Biotech Holdings Additional Paid-In Capital Calculation

Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital=(Issue Price-Par Value)* Shares Outstanding (Diluted Average)

Viva Biotech Holdings Additional Paid-In Capital Related Terms

Thank you for viewing the detailed overview of Viva Biotech Holdings's Additional Paid-In Capital provided by GuruFocus.com. Please click on the following links to see related term pages.


Viva Biotech Holdings Business Description

Traded in Other Exchanges
Address
735 Ziping Road, Pudong New District, Zhoupu Town, Shanghai, CHN, 201318
Viva Biotech Holdings is engaged in providing the structure-based drug discovery services to biotechnology and pharmaceutical customers for their pre-clinical stage drug development. The company operates in three reportable segments, Drug Discovery Services providing structure-based drug discovery services to biotechnology and pharmaceutical customers for their pre-clinical stage drug development; Contract Development Manufacture Organisation providing contract development and manufacturing services for small molecule APIs and intermediates and trading of APIs, intermediates and formulations; and commercialisation services; and Viva BioInnovator making strategic investments in biotechnology startup companies.

Viva Biotech Holdings Headlines

No Headlines